Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 14/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.42 |
| ▸ | SCN1A | P35498 | 1/20 | 0.42 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.42 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4390592 | 1.00 | HRH3 (0.50) | HRH3KCNH2SCN1ASCN2ASCN3A | |
| SCHEMBL4388413 | 1.00 | HRH3 (0.50) | HRH3KCNH2SCN1ASCN2ASCN3A | |
| SCHEMBL4385874 | 1.00 | HRH3 (0.50) | HRH3KCNH2SCN1ASCN2ASCN3A | |
| SCHEMBL4389577 | 1.00 | HRH3 (0.50) | HRH3KCNH2SCN1ASCN2ASCN3A | |
| Hydrochloric Acid SCHEMBL4385829 | 0.99 | HRH3 (0.49) | HRH3KCNH2SCN1ASCN2ASCN3A | |
| SCHEMBL4382833 | 0.98 | HRH3 (0.54) | HRH3KCNH2SCN1ASCN2ASCN3A | |
| SCHEMBL4382832 | 0.98 | HRH3 (0.54) | HRH3KCNH2SCN1ASCN2ASCN3A | |
| SCHEMBL4388789 | 0.98 | HRH3 (0.54) | HRH3KCNH2SCN1ASCN2ASCN3A | |
| SCHEMBL4388791 | 0.98 | HRH3 (0.54) | HRH3KCNH2SCN1ASCN2ASCN3A | |
| SCHEMBL4388027 | 0.92 | HRH3 (0.43) | HRH3KCNH2SCN1ASCN2ASCN3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090181948-A1 | DIAMINE DERIVATIVE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2009-07-16 | — | — | US | disclosed |
| EP-1847530-A1 | DIAMINE DERIVATIVE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2007-10-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090181948-A1 | DIAMINE DERIVATIVE | ARG1, PRMT5, PRMT1 | HRH3 452/4885KCNH2 1776/4885SCN1A 4418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.